Ω76: A designed antimicrobial peptide to combat carbapenem- and tigecycline-resistant Acinetobacter baumannii

Drug resistance is a public health concern that threatens to undermine decades of medical progress. ESKAPE pathogens cause most nosocomial infections, and are frequently resistant to carbapenem antibiotics, usually leaving tigecycline and colistin as the last treatment options. However, increasing t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagarajan, Deepesh, Roy, Natasha, Kulkarni, Omkar, Nanajkar, Neha, Datey, Akshay, Ravichandran, Sathyabaarathi, Thakur, Chandrani, T., Sandeep, Aprameya, Indumathi V., Sarma, Siddhartha P., Chakravortty, Dipshikha, Chandra, Nagasuma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656545/
https://www.ncbi.nlm.nih.gov/pubmed/31355341
http://dx.doi.org/10.1126/sciadv.aax1946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656545/
https://www.ncbi.nlm.nih.gov/pubmed/31355341
http://dx.doi.org/10.1126/sciadv.aax1946

Ejemplares similares